Skip to main content
Clinical Trials/CTRI/2022/05/042700
CTRI/2022/05/042700
Completed
Phase 2

A randomized clinical trial on the comparative efficacy of Gandharyadi Ghrita Nasya and Dashmooladi Ghrita Nasya along with Dhatryadi Ghan Vati orally in Ardhavabhedaka with special reference to Migraine

ational Institute of Ayurveda Jaipur0 sites30 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: G439- Migraine, unspecified
Sponsor
ational Institute of Ayurveda Jaipur
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 30, 2022
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
ational Institute of Ayurveda Jaipur

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients willing to participate in this trial through written informed consent.
  • 2\.Both fresh and treated patients.
  • 3\.Patients between18 to 60 years of age from either sex.
  • 4\.Patients presenting with symptoms of Ardhavabhedaka vis\-à\-vis Migraine.

Exclusion Criteria

  • 1\.Patients of age less than 18 and greater than 60
  • 2\.Patients with referred pain in one half of head due to other secondary reasons such as anxiety, refractive errors etc. rather than migraine.
  • 3\.Patients with complicated Migraine like hemiplegic migraine and having any chronic debilitating disease with other neurological pathology.
  • 4\.Pregnant and lactating women.
  • 5\.Patients suffering from any other major systemic disorders which interfare with course of treatment.

Outcomes

Primary Outcomes

Not specified

Similar Trials